mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |